Givaudan | GIVN - Nettoeinkommen

Aktienkurs
2,789.50
Täglich Wechseln
54.50 1.99%
Monatlich
3.20%
Jährlich
-30.00%
Q2 Prognose
2,730.14




Nettoeinkommen Veränderung Datum
Air Liquide EUR 1.72B 84.3M 2025-12
Akzo Nobel EUR 93M 505M 2026-03
Anheuser-Busch USD 2.56B 604M 2026-03
Arkema EUR 27.2M 119.2M 2026-03
Associated British Foods GBP 445M 60M 2026-06
BASF EUR 927M 367M 2026-03
Bayer EUR -3.76B 2.79B 2025-12
Beiersdorf EUR 387M 165M 2025-12
British American Tobacco GBP 3.25B 1.26B 2025-12
Covestro EUR -378M 331M 2025-12
Croda International GBP 78.7M 38.8M 2024-12
Danone EUR 778M 260M 2025-12
Diageo GBP 2B 1.58B 2025-12
Fresenius EUR 361M 17M 2025-12
Fresenius Medical Care EUR 118M 209M 2026-03
Givaudan CHF 479M 113M 2025-12
Heineken EUR 1.14B 397M 2025-12
Henkel EUR 925M 185M 2025-12
International Flavors Fragrances USD 169M 151M 2026-03
Johnson Matthey GBP -18M 93M 2025-12
Kerry EUR 442.9M 151.4M 2024-12
Lonza CHF 426M 119M 2025-06
L'Oréal EUR 2.76B 608.8M 2025-12
Merck EUR 319M 583M 2025-12
Nestle CHF 3.97B 1.1B 2025-12
Pernod Ricard EUR 975M 539M 2025-12
Reckitt Benckiser GBP 284M 287M 2024-12
SGS CHF 157M 23.5M 2024-12
Sika AG CHF 490.2M 63.6M 2025-12
Solvay EUR -95M 129M 2025-12
Tate & Lyle GBP 56M 78M 2025-12
Umicore EUR 247.85M 111.15M 2025-12
Victrex GBP 12.6M 2.6M 2025-12